Dongyao Hou

428 total citations · 1 hit paper
9 papers, 318 citations indexed

About

Dongyao Hou is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Dongyao Hou has authored 9 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Epidemiology and 1 paper in Infectious Diseases. Recurrent topics in Dongyao Hou's work include Mitochondrial Function and Pathology (4 papers), Autophagy in Disease and Therapy (3 papers) and ATP Synthase and ATPases Research (3 papers). Dongyao Hou is often cited by papers focused on Mitochondrial Function and Pathology (4 papers), Autophagy in Disease and Therapy (3 papers) and ATP Synthase and ATPases Research (3 papers). Dongyao Hou collaborates with scholars based in China, United Kingdom and Singapore. Dongyao Hou's co-authors include Chenyang Duan, He Huang, Xue Zeng, Tao Li, Xinming Xiang, Yundong Zhang, Ruixue Liu, Shuai Hao, Liangming Liu and Jun Guo and has published in prestigious journals such as Free Radical Biology and Medicine, Frontiers in Immunology and Advanced Science.

In The Last Decade

Dongyao Hou

9 papers receiving 314 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis

2022 207 citations Xue Zeng, Yundong Zhang et al. Military Medical Research profile →

Peers

Dongyao Hou

MB

EPIDE

CR

NEURO

PRM

Xue Zeng China

Tianlin Long China

Jiefang Chen China

Wenzhao Liang China

Xue Peng China

Shijia Yu China

Liang Huo China

Hongqiang Yu China

Zhongmin Fan China

Shan Sun China

Xue Zeng China

Dongyao Hou

219 ×1.1

MB

77 ×1.0

EPIDE

71 ×1.1

CR

62 ×1.0

NEURO

50 ×1.1

PRM

Citations per year, relative to Dongyao Hou Dongyao Hou (= 1×) peers Xue Zeng

Countries citing papers authored by Dongyao Hou

Since Specialization

Citations

This map shows the geographic impact of Dongyao Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyao Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyao Hou more than expected).

Fields of papers citing papers by Dongyao Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongyao Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyao Hou. The network helps show where Dongyao Hou may publish in the future.

Co-authorship network of co-authors of Dongyao Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Dongyao Hou. A scholar is included among the top collaborators of Dongyao Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongyao Hou. Dongyao Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Hao, Shuai, Dongyao Hou, Ruixue Liu, et al.. (2024). TSPO exacerbates sepsis-induced cardiac dysfunction by inhibiting p62-Mediated autophagic flux via the ROS-RIP1/RIP3-exosome axis. Free Radical Biology and Medicine. 226. 56–69. 6 indexed citations

2.

Li, Fengjuan, Shuai Hao, Dongyao Hou, et al.. (2024). Low-dose Olaparib improves septic cardiac function by reducing ferroptosis via accelerated mitophagy flux. Pharmacological Research. 200. 107056–107056. 25 indexed citations

3.

Liu, Ruixue, Weilong Hong, Dongyao Hou, He Huang, & Chenyang Duan. (2024). Decoding Organelle Interactions: Unveiling Molecular Mechanisms and Disease Therapies. Advanced Biology. 8(7). e2300288–e2300288. 3 indexed citations

4.

Liu, Ruixue, He Huang, Dongyao Hou, et al.. (2024). Unfractionated Heparin Enhances Sepsis Prognosis Through Inhibiting Drp1‐Mediated Mitochondrial Quality Imbalance. Advanced Science. 11(46). e2407705–e2407705. 2 indexed citations

5.

Hou, Dongyao, et al.. (2024). Curcumin simultaneously improves mitochondrial dynamics and myocardial cell bioenergy after sepsis via the SIRT1-DRP1/PGC-1α pathway. Heliyon. 10(7). e28501–e28501. 23 indexed citations

6.

Hou, Dongyao, Ruixue Liu, Shuai Hao, et al.. (2024). Notoginsenoside R1 improves intestinal microvascular functioning in sepsis by targeting Drp1-mediated mitochondrial quality imbalance. Pharmaceutical Biology. 62(1). 250–260. 5 indexed citations

7.

Duan, Chenyang, Ruixue Liu, Lei Kuang, et al.. (2023). Activated Drp1 Initiates the Formation of Endoplasmic Reticulum‐Mitochondrial Contacts via Shrm4‐Mediated Actin Bundling. Advanced Science. 10(36). e2304885–e2304885. 24 indexed citations

8.

Zeng, Xue, Yundong Zhang, Xinming Xiang, et al.. (2022). Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis. Military Medical Research. 9(1). 25–25. 207 indexed citations breakdown →

9.

Duan, Chenyang, Ruiyan Ma, Xue Zeng, et al.. (2022). SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19. Frontiers in Immunology. 13. 946731–946731. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact